| What is new in computer vision and artificial intelligence in medical image analysis applications J Olveres, G González, F Torres, JC Moreno-Tagle, E Carbajal-Degante, ... Quantitative imaging in medicine and surgery 11 (8), 3830, 2021 | 63 | 2021 |
| The cellular pathways of liver fibrosis in non-alcoholic steatohepatitis N Méndez-Sánchez, A Valencia-Rodríguez, C Coronel-Castillo, ... Annals of Translational Medicine 8 (6), 2020 | 49 | 2020 |
| What has the COVID-19 pandemic taught us so far? Addressing the problem from a hepatologist’s perspective N Méndez-Sánchez, A Valencia-Rodríguez, X Qi, EM Yoshida, ... Journal of clinical and translational hepatology 8 (2), 109, 2020 | 39 | 2020 |
| Dyslipidemia as a risk factor for liver fibrosis progression in a multicentric population with non-alcoholic steatohepatitis N Méndez-Sánchez, E Cerda-Reyes, F Higuera-de-la-Tijera, ... F1000Research 9, 2020 | 37 | 2020 |
| The mechanism of dysbiosis in alcoholic liver disease leading to liver cancer N Méndez-Sánchez, A Valencia-Rodríguez, A Vera-Barajas, L Abenavoli, ... Hepatoma research 6, 2020 | 36 | 2020 |
| Looking into a new era for the approach of metabolic (dysfunction) associated fatty liver disease A Valencia-Rodríguez, A Vera-Barajas, NC Chávez-Tapia, M Uribe, ... Annals of hepatology 19 (3), 227-229, 2020 | 31 | 2020 |
| New insights into the association between non-alcoholic fatty liver disease and atherosclerosis A Valencia-Rodríguez, A Vera-Barajas, B Barranco-Fragoso, ... Annals of Translational Medicine 7 (Suppl 8), 2019 | 16 | 2019 |
| Caveats for the implementation of global strategies against non-alcoholic fatty liver disease N Méndez-Sánchez, A Valencia-Rodríguez Journal of Hepatology 73 (1), 220, 2020 | 11 | 2020 |
| The mechanism of dysbiosis in alcoholic liver disease leading to liver cancer. Hepatoma Res 2020; 6: 5 N Méndez-Sánchez, A Valencia-Rodriguez, A Vera-Barajas, L Abenavoli, ... | 5 | |
| Long-standing effect of cholecystectomy in patients with metabolic-associated fatty liver disease N Méndez-Sánchez, A Valencia-Rodríguez, E Cerda-Reyes, ... European Journal of Gastroenterology & Hepatology 33 (1S), e824-e830, 2021 | 4 | 2021 |
| Narrative review of hepatocellular carcinoma: from molecular bases to therapeutic approach N Méndez-Sánchez, A Valencia-Rodríguez, CE Coronel-Castillo, X Qi Digestive Medicine Research 4, 2021 | 3 | 2021 |
| New therapeutic options for bile acid malabsorption diarrhea A Valencia-Rodríguez, J Aquino-Matus, A Vera-Barajas, X Qi, ... Annals of Translational Medicine 7 (22), 2019 | 3 | 2019 |
| Long-standing cholecystectomy as a risk factor for advanced fibrosis in patients with non-alcoholic fatty liver disease: an observational multicenter study N Mendez-Sanchez, A Valencia-Rodriguez, E Cerda Reyes, ... HEPATOLOGY 72, 256A-256A, 2020 | 1 | 2020 |
| Stories review of hepatocellular tumor: from molecular bases to therapeutic approach N Méndez-Sánchez, A Valencia-Rodríguez, CE Coronel-Castillo, X Qi Narrative 4, 2021 | | 2021 |
| Narrative review of the molecular pathways of cholangiocarcinoma: current and future applications in management CE Coronel-Castillo, A Valencia-Rodríguez, X Qi, N Méndez-Sánchez Digestive Medicine Research 3, 2020 | | 2020 |
| Hepatocellular adenoma in the context of non-alcoholic steatohepatitis: a case report of an unusual presentation more and more frequent? N Méndez-Sánchez, A Valencia-Rodríguez, C Ortiz-Hidalgo, X Qi Digestive Medicine Research 3, 2020 | | 2020 |
| Encefalopatía hepática. Conceptos actuales N Méndez-Sánchez, CEC Castillo, JC Carmona, AV Rodríguez, ... | | |
